ArticleEMBO molecular medicine2024

FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer.

Nicla Lorito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.